Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Mechanisms in PMDD
NCT02508103Phase 3Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jul 2015
- Primary completion
- Jun 2016
- Countries
- 1
01
Overview
A Phase 3 trial of oxytocin nasal spray in Premenstrual Dysphoric Disorder (PMDD), sponsored by University of North Carolina at Chapel Hill. Started Jul 2015; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on NCT02508103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02508103.